Molecular profiling in pancreatic adenocarcinoma (PDAC) has gained traction and we recently demonstrated that targeting actionable alterations can improve patient (pt) outcomes using the Perthera Platform’s real-world evidence database.
Comprehensive Analysis of KRAS Variants in Patients (Pts) with Pancreatic Cancer
AI-enabled precision, speed and scale
Precision oncology and speed to decision, for everyone, at every point of care.
How We Help